Affinity Asset Advisors, LLC Olema Pharmaceuticals, Inc. Transaction History
Affinity Asset Advisors, LLC
- $896 Million
- Q1 2025
A detailed history of Affinity Asset Advisors, LLC transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 325,000 shares of OLMA stock, worth $1.51 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
325,000Holding current value
$1.51 Million% of portfolio
0.14%Shares
2 transactions
Others Institutions Holding OLMA
# of Institutions
132Shares Held
64.9MCall Options Held
6.3KPut Options Held
15.2K-
Bain Capital Life Sciences Investors, LLC Boston, MA6.84MShares$31.8 Million8.64% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY6.74MShares$31.3 Million1.3% of portfolio
-
Bvf Inc San Francisco, CA5.3MShares$24.6 Million0.88% of portfolio
-
Black Rock Inc. New York, NY4MShares$18.6 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.44MShares$16 Million0.45% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $188M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...